Recruiting studies: Neoadjuvant Chemoimmunotherapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer
Phase 2 · 2 location(s) · Tongji Hospital · NCT06289751 NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients
Phase 2 · 1 location(s) · Medical University of South Carolina · NCT06845319 Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CR
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06509568 Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
NA · 1 location(s) · Anhui Provincial Hospital · NCT06602843 TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemo
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07330037 Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage
Phase 2 · 1 location(s) · Shanghai Pulmonary Hospital, Shanghai, China · NCT05503667 Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer
Phase 2 · 1 location(s) · Fudan University · NCT06039631 Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurg
Phase 1 · 1 location(s) · Shanghai Zhongshan Hospital · NCT07317609 Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma
Phase 2/Phase 3 · 1 location(s) · Peking Union Medical College Hospital · NCT06907602 Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
Phase N/A · 10 location(s) · Shanghai Chest Hospital · NCT07528066 NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a F
Phase 1/Phase 2 · 1 location(s) · University Hospital, Antwerp · NCT07121374 Tumor Margin Skin Tattooing Before Neo-adjuvant Chemotherapy in Patients With Breast Cancer
NA · 1 location(s) · All India Institute of Medical Sciences, Bhubaneswar · NCT07478900 The Value of CEUS in Assessing the Response of Cervical Lymph Nodes After NACI for HNSCC
Phase N/A · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06727162 Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
Phase 2/Phase 3 · 12 location(s) · Tongji Hospital · NCT06288373 A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After R
Phase 2 · 1 location(s) · Zeng Jian · NCT06424899 Prospective Cohort Study on Oral Microbiome Changes in Patients With Locally Advanced Oral Squamous Cell Carcinoma Follo
Phase N/A · 1 location(s) · Zhujiang Hospital · NCT07111455 Imaging-based PRediction of Eligibility for ChemoImmunotherapy in reSEctable NSCLC, iPRECISE
Phase N/A · 1 location(s) · Samsung Medical Center · NCT07559123 Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junctio
Phase 2 · 1 location(s) · Daping Hospital and the Research Institute of Surgery of the · NCT07165847 HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer
Phase 2 · 1 location(s) · Daping Hospital and the Research Institute of Surgery of the · NCT06709885 Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
NA · 1 location(s) · Centre Henri Becquerel · NCT06879704 Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer
Phase N/A · 1 location(s) · Central South University · NCT07063901 Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma
Phase 2 · 1 location(s) · Guo Xufeng · NCT06056336 The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC
Phase 2 · 2 location(s) · Fifth Affiliated Hospital, Sun Yat-Sen University · NCT05343325 Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Phase N/A · 1 location(s) · Shanghai Zhongshan Hospital · NCT05740995 Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
Phase 2 · 1 location(s) · Weill Medical College of Cornell University · NCT06623656 RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
Phase N/A · 10 location(s) · Shanghai Chest Hospital · NCT07541521 Neoadjuvant Immunochemotherapy in PD-L1-negative LACC
Phase 2 · 12 location(s) · Tongji Hospital · NCT06288360 SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06219980 Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer
Phase 2 · 3 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06421376 Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
Phase 2 · 2 location(s) · Tongji Hospital · NCT06289062

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.